https:\/\/investor.hcahealthcare.com\/events-and-presentations\/default.aspx<\/a>.\n<\/p>\nAbout the Company<\/b><\/p>\n
\nAs of June 30, 2021, HCA operated 187 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 20 states and the United Kingdom.\n<\/p>\n
Forward-Looking Statements<\/span><\/b><\/p>\n\nThis press release contains forward-looking statements within the meaning of the federal securities laws, which involve risks and uncertainties. Forward-looking statements include the Company\u2019s financial guidance for the year ending December 31, 2021, as well as other statements that do not relate solely to historical or current facts. Forward-looking statements can be identified by the use of words like \u201cmay,\u201d \u201cbelieve,\u201d \u201cwill,\u201d \u201cexpect,\u201d \u201cproject,\u201d \u201cestimate,\u201d \u201canticipate,\u201d \u201cplan,\u201d \u201cinitiative\u201d or \u201ccontinue.\u201d These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, (1) developments related to COVID-19, including, without limitation, the length and severity of the pandemic and the spread of virus strains with new epidemiological characteristics; the volume of canceled or rescheduled procedures and the volume of COVID-19 patients cared for across our health systems; measures we are taking to respond to the COVID-19 pandemic; the impact and terms of government and administrative regulation and stimulus (including the Families First Coronavirus Response Act, the Coronavirus Aid, Relief and Economic Security (\u201cCARES\u201d) Act, the Paycheck Protection Program and Health Care Enhancement Act, the Consolidated Appropriations Act, 2021, the American Rescue Plan Act of 2021 and other enacted and potential future legislation); changes in revenues due to declining patient volumes, changes in payer mix and deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients); potential increased expenses related to labor, supply chain or other expenditures; workforce disruptions; supply shortages and disruptions; and the timing, availability and adoption of effective medical treatments and vaccines, (2) the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms, as well as risks associated with disruptions in the financial markets and the business of financial institutions as the result of the COVID-19 pandemic which could impact us from a financial perspective, (3) the impact of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the \u201cAffordable Care Act\u201d), including the effects of changes or court challenges to the Affordable Care Act or additional changes to its implementation, the possible enactment of additional federal or state health care reforms and possible changes to other federal, state or local laws or regulations affecting the health care industry, including proposals to expand coverage of federally-funded insurance programs as an alternative to private insurance or establish a single-payer system (such reforms often referred to as \u201cMedicare for All\u201d), and also including any such laws or governmental regulations which are adopted in response to the COVID-19 pandemic, (4) the effects related to the implementation of sequestration spending reductions required under the Budget Control Act of 2011, related legislation extending these reductions, and those required under the Pay-As-You-Go Act of 2010 (\u201cPAYGO Act\u201d) as a result of the federal budget deficit impact of the American Rescue Plan Act of 2021, and the potential for future deficit reduction legislation that may alter these spending reductions, which include cuts to Medicare payments, or create additional spending reductions, (5) increases in the amount and risk of collectability of uninsured accounts and deductibles and copayment amounts for insured accounts, (6) the ability to achieve operating and financial targets, and attain expected levels of patient volumes and control the costs of providing services, (7) possible changes in Medicare, Medicaid and other state programs, including Medicaid supplemental payment programs or Medicaid waiver programs, that may impact reimbursements to health care providers and insurers and the size of the uninsured or underinsured population, (8) the highly competitive nature of the health care business, (9) changes in service mix, revenue mix and surgical volumes, including potential declines in the population covered under third-party payer agreements, the ability to enter into and renew third-party payer provider agreements on acceptable terms and the impact of consumer-driven health plans and physician utilization trends and practices, (10) the efforts of health insurers, health care providers, large employer groups and others to contain health care costs, (11) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (12) increases in wages and the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical and technical support personnel, (13) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (14) changes in accounting practices, (15) changes in general economic conditions nationally and regionally in our markets, including economic and business conditions (and the impact thereof on the economy, financial markets and banking industry) resulting from the COVID-19 pandemic, (16) the emergence of and effects related to other pandemics, epidemics and infectious diseases, (17) future divestitures which may result in charges and possible impairments of long-lived assets, (18) changes in business strategy or development plans, (19) delays in receiving payments for services provided, (20) the outcome of pending and any future tax audits, disputes and litigation associated with our tax positions, (21) potential adverse impact of known and unknown government investigations, litigation and other claims that may be made against us, (22) the impact of potential cybersecurity incidents or security breaches, (23) our ongoing ability to demonstrate meaningful use of certified electronic health record (\u201cEHR\u201d) technology and the impact of interoperability requirements, (24) the impact of natural disasters, such as hurricanes and floods, or similar events beyond our control, (25) changes in the U.S. federal, state, or foreign tax laws including interpretive guidance that may be issued by taxing authorities or other standard setting bodies, and (26) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2020 and our other filings with the Securities and Exchange Commission. Many of the factors that will determine our future results are beyond our ability to control or predict. In light of the significant uncertainties inherent in the forward-looking statements contained herein, readers should not place undue reliance on forward-looking statements, which reflect management\u2019s views only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.\n<\/p>\n
\nAll references to \u201cCompany\u201d and \u201cHCA Healthcare\u201d as used throughout this release refer to HCA Healthcare, Inc. and its affiliates.\n<\/p>\n
\n\nHCA Healthcare, Inc.<\/b><\/td>\n<\/tr>\n\nCondensed Consolidated Comprehensive Income Statements<\/b><\/td>\n<\/tr>\n\nSecond Quarter<\/b><\/td>\n<\/tr>\n\n(Dollars in millions, except per share amounts)<\/b><\/td>\n<\/tr>\n\n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n | <\/tr>\n \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n | <\/tr>\n \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n | <\/tr>\n \n| ($ millions, except per share amounts)<\/td>\n | | \n\n 2021<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n2020\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \nAmount<\/span><\/b><\/td>\n | Ratio<\/span><\/b><\/td>\n | | \n\u00a0<\/td>\n | Amount<\/span><\/td>\n | \u00a0<\/td>\n | Ratio<\/span><\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n | <\/tr>\n \n| Revenues<\/td>\n | | \n | \n\n $14,435<\/b><\/p>\n<\/td>\n | \n 100.0<\/b><\/p>\n<\/td>\n | %<\/b><\/td>\n | \u00a0<\/td>\n | \n \n$11,068\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n100.0\n<\/p>\n<\/td>\n | %<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n | <\/tr>\n \n| Salaries and benefits<\/td>\n | | \n | \n\n 6,385<\/b><\/p>\n<\/td>\n | \n 44.2<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n5,330\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n48.2\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Supplies<\/td>\n | | \n | \n\n 2,380<\/b><\/p>\n<\/td>\n | \n 16.5<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n1,748\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n15.8\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Other operating expenses<\/td>\n | | \n | \n\n 2,473<\/b><\/p>\n<\/td>\n | \n 17.2<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n2,147\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n19.3\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Government stimulus income<\/td>\n | | \n | \n\n –<\/b><\/p>\n<\/td>\n | \n –<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n(822)\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n(7.4)\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Equity in earnings of affiliates<\/td>\n | | \n\n (22)<\/b><\/p>\n<\/td>\n | \n (0.2)<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n(1)\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n–\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Depreciation and amortization<\/td>\n | | \n\n 712<\/b><\/p>\n<\/td>\n | \n 4.9<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n691\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n6.3\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Interest expense<\/td>\n | | \n | \n\n 386<\/b><\/p>\n<\/td>\n | \n 2.7<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n388\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n3.5\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Losses (gains) on sales of facilities<\/td>\n | | \n\n (8)<\/b><\/p>\n<\/td>\n | \n (0.1)<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n27\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n0.2\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Losses on retirement of debt<\/td>\n | | \n | \n\n 12<\/b><\/p>\n<\/td>\n | \n 0.1<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n–\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n–\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n | <\/tr>\n \n | \n | \n | \n\n 12,318<\/b><\/p>\n<\/td>\n | \n 85.3<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n9,508\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n85.9\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n | <\/tr>\n \n| Income before income taxes<\/td>\n | | \n | \n\n 2,117<\/b><\/p>\n<\/td>\n | \n 14.7<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n1,560\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n14.1\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n | <\/tr>\n \n| Provision for income taxes<\/td>\n | | \n | \n\n 453<\/b><\/p>\n<\/td>\n | \n 3.2<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n344\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n3.1\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n | <\/tr>\n \n| Net income<\/td>\n | | \n | \n\n 1,664<\/b><\/p>\n<\/td>\n | \n 11.5<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n1,216\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n11.0\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n | <\/tr>\n \n| Net income attributable to noncontrolling interests<\/td>\n | | \n\n 214<\/b><\/p>\n<\/td>\n | \n 1.5<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n137\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n1.2\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n | <\/tr>\n \n| Net income attributable to HCA Healthcare, Inc.<\/td>\n | | \n\n $1,450<\/b><\/p>\n<\/td>\n | \n 10.0<\/b><\/p>\n<\/td>\n | | \n\u00a0<\/td>\n | \n \n$1,079\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n9.8\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n | <\/tr>\n \n| Diluted earnings per share<\/td>\n | | \n | \n\n $4.36<\/b><\/p>\n<\/td>\n | | \n | \n\u00a0<\/td>\n | \n \n$3.16\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n | <\/tr>\n \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n | <\/tr>\n \n| Shares used in computing diluted earnings per share (millions)<\/td>\n | | \n\n 332.613<\/b><\/p>\n<\/td>\n | | \n | \n\u00a0<\/td>\n | \n \n341.599\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n | <\/tr>\n \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n | <\/tr>\n \n| Comprehensive income attributable to HCA Healthcare, Inc.<\/td>\n | | \n\n $1,466<\/b><\/p>\n<\/td>\n | | \n | \n\u00a0<\/td>\n | \n \n$1,088\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n | <\/tr>\n<\/table>\n\n\nCondensed Consolidated Comprehensive Income Statements<\/b><\/td>\n<\/tr>\n\nFor the Six Months Ended June 30, 2021 and 2020<\/b><\/td>\n<\/tr>\n\n(Dollars in millions, except per share amounts)<\/b><\/td>\n<\/tr>\n\n | \n | \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n | \n | \n\n 2021<\/b><\/p>\n<\/td>\n | | \n\n \n2020\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \nAmount<\/span><\/b><\/td>\n | Ratio<\/span><\/b><\/td>\n | | \nAmount<\/span><\/td>\n | Ratio<\/span><\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Revenues<\/td>\n | | \n | \n\n $28,412<\/b><\/p>\n<\/td>\n | \n 100.0<\/b><\/p>\n<\/td>\n | \n %<\/b><\/p>\n<\/td>\n | \n \n$23,929\n<\/p>\n<\/td>\n | \n \n100.0\n<\/p>\n<\/td>\n | \n \n%\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Salaries and benefits<\/td>\n | | \n | \n\n 12,686<\/b><\/p>\n<\/td>\n | \n 44.6<\/b><\/p>\n<\/td>\n | | \n\n \n11,448\n<\/p>\n<\/td>\n | \n \n47.8\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Supplies<\/td>\n | | \n | \n\n 4,604<\/b><\/p>\n<\/td>\n | \n 16.2<\/b><\/p>\n<\/td>\n | | \n\n \n3,871\n<\/p>\n<\/td>\n | \n \n16.2\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Other operating expenses<\/td>\n | | \n | \n\n 4,894<\/b><\/p>\n<\/td>\n | \n 17.3<\/b><\/p>\n<\/td>\n | | \n\n \n4,574\n<\/p>\n<\/td>\n | \n \n19.1\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Government stimulus income<\/td>\n | | \n | \n\n –<\/b><\/p>\n<\/td>\n | \n –<\/b><\/p>\n<\/td>\n | | \n\n \n(822)\n<\/p>\n<\/td>\n | \n \n(3.4)\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Equity in earnings of affiliates<\/td>\n | | \n\n (43)<\/b><\/p>\n<\/td>\n | \n (0.2)<\/b><\/p>\n<\/td>\n | | \n\n \n(8)\n<\/p>\n<\/td>\n | \n \n–\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Depreciation and amortization<\/td>\n | | \n\n 1,409<\/b><\/p>\n<\/td>\n | \n 5.0<\/b><\/p>\n<\/td>\n | | \n\n \n1,365\n<\/p>\n<\/td>\n | \n \n5.7\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Interest expense<\/td>\n | | \n | \n\n 770<\/b><\/p>\n<\/td>\n | \n 2.7<\/b><\/p>\n<\/td>\n | | \n\n \n816\n<\/p>\n<\/td>\n | \n \n3.4\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Losses (gains) on sales of facilities<\/td>\n | | \n\n (10)<\/b><\/p>\n<\/td>\n | \n –<\/b><\/p>\n<\/td>\n | | \n\n \n20\n<\/p>\n<\/td>\n | \n \n0.1\n<\/p>\n<\/td>\n | | <\/tr>\n \n| Losses on retirement of debt<\/td>\n | | \n | \n\n 12<\/b><\/p>\n<\/td>\n | \n –<\/b><\/p>\n<\/td>\n | | \n\n \n295\n<\/p>\n<\/td>\n | \n \n1.2\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n | \n | \n | \n\n 24,322<\/b><\/p>\n<\/td>\n | \n 85.6<\/b><\/p>\n<\/td>\n | | \n\n \n21,559\n<\/p>\n<\/td>\n | \n \n90.1\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Income before income taxes<\/td>\n | | \n | \n\n 4,090<\/b><\/p>\n<\/td>\n | \n 14.4<\/b><\/p>\n<\/td>\n | | \n\n \n2,370\n<\/p>\n<\/td>\n | \n \n9.9\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Provision for income taxes<\/td>\n | | \n | \n\n 846<\/b><\/p>\n<\/td>\n | \n 3.0<\/b><\/p>\n<\/td>\n | | \n\n \n456\n<\/p>\n<\/td>\n | \n \n1.9\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Net income<\/td>\n | | \n | \n\n 3,244<\/b><\/p>\n<\/td>\n | \n 11.4<\/b><\/p>\n<\/td>\n | | \n\n \n1,914\n<\/p>\n<\/td>\n | \n \n8.0\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Net income attributable to noncontrolling interests<\/td>\n | | \n\n 371<\/b><\/p>\n<\/td>\n | \n 1.3<\/b><\/p>\n<\/td>\n | | \n\n \n254\n<\/p>\n<\/td>\n | \n \n1.1\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Net income attributable to HCA Healthcare, Inc.<\/td>\n | | \n\n $2,873<\/b><\/p>\n<\/td>\n | \n 10.1<\/b><\/p>\n<\/td>\n | | \n\n \n$1,660\n<\/p>\n<\/td>\n | \n \n6.9\n<\/p>\n<\/td>\n | | <\/tr>\n \n | \n | \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Diluted earnings per share<\/td>\n | | \n | \n\n $8.50<\/b><\/p>\n<\/td>\n | | \n | \n\n \n$4.84\n<\/p>\n<\/td>\n | | \n | <\/tr>\n \n | \n | \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Shares used in computing diluted earnings per share (millions)<\/td>\n | | \n\n 337.940<\/b><\/p>\n<\/td>\n | | \n | \n\n \n342.848\n<\/p>\n<\/td>\n | | \n | <\/tr>\n \n | \n | \n | \n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Comprehensive income attributable to HCA Healthcare, Inc.<\/td>\n | | \n\n $2,900<\/b><\/p>\n<\/td>\n | | \n | \n\n \n$1,558\n<\/p>\n<\/td>\n | | \n | <\/tr>\n<\/table>\n\n\nHCA Healthcare, Inc.<\/b><\/td>\n<\/tr>\n\nCondensed Consolidated Balance Sheets<\/b><\/td>\n<\/tr>\n\n(Dollars in millions)<\/b><\/td>\n<\/tr>\n\n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | \u00a0<\/td>\n<\/tr>\n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | \u00a0<\/td>\n<\/tr>\n | \n | \nJune 30,<\/b><\/td>\n | \u00a0<\/td>\n | March 31,<\/b><\/td>\n | \u00a0<\/td>\n | December 31,<\/b><\/td>\n<\/tr>\n\n | \n\n 2021<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 2021<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 2020<\/b><\/p>\n<\/td>\n<\/tr>\n\n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | \u00a0<\/td>\n<\/tr>\n | \n| ASSETS<\/b><\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Current assets:<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Cash and cash equivalents<\/td>\n | \n $1,120<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$1,030\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$1,793\n<\/p>\n<\/td>\n<\/tr>\n | \n| Accounts receivable<\/td>\n | \n 7,636<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n7,424\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n7,051\n<\/p>\n<\/td>\n<\/tr>\n | \n| Inventories<\/td>\n | \n 2,027<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n2,068\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n2,025\n<\/p>\n<\/td>\n<\/tr>\n | \n| Other<\/td>\n | \n 1,692<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n1,514\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n1,464\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n\n 12,475<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n12,036\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n12,333\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | \u00a0<\/td>\n<\/tr>\n | \n| Property and equipment, at cost<\/td>\n | \n 50,698<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n49,877\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n49,317\n<\/p>\n<\/td>\n<\/tr>\n | \n| Accumulated depreciation<\/td>\n | \n (27,227)<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n(26,689)\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n(26,118)\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n\n 23,471<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n23,188\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n23,199\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | \u00a0<\/td>\n<\/tr>\n | \n| Investments of insurance subsidiaries<\/td>\n | \n 410<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n393\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n388\n<\/p>\n<\/td>\n<\/tr>\n | \n| Investments in and advances to affiliates<\/td>\n | \n 382<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n427\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n422\n<\/p>\n<\/td>\n<\/tr>\n | \n| Goodwill and other intangible assets<\/td>\n | \n 8,680<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n8,575\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n8,578\n<\/p>\n<\/td>\n<\/tr>\n | \n| Right-of-use operating lease assets<\/td>\n | \n 2,118<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n2,083\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n2,024\n<\/p>\n<\/td>\n<\/tr>\n | \n| Other<\/td>\n | \n 628<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n575\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n546\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | \u00a0<\/td>\n<\/tr>\n | \n | \n\n $48,164<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$47,277\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$47,490\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | \u00a0<\/td>\n<\/tr>\n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | \u00a0<\/td>\n<\/tr>\n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | \u00a0<\/td>\n<\/tr>\n | \n| LIABILITIES AND STOCKHOLDERS’ EQUITY<\/b><\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Current liabilities:<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Accounts payable<\/td>\n | \n $3,531<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$3,524\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$3,535\n<\/p>\n<\/td>\n<\/tr>\n | \n| Accrued salaries<\/td>\n | \n 1,896<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n1,767\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n1,720\n<\/p>\n<\/td>\n<\/tr>\n | \n| Other accrued expenses<\/td>\n | \n 2,935<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n3,117\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n3,240\n<\/p>\n<\/td>\n<\/tr>\n | \n| Long-term debt due within one year<\/td>\n | \n 253<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n234\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n209\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n\n 8,615<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n8,642\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n8,704\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | \u00a0<\/td>\n<\/tr>\n | \n| Long-term debt, less debt issuance costs and discounts of $255, $229 and $236<\/td>\n | \n 32,319<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n30,838\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n30,795\n<\/p>\n<\/td>\n<\/tr>\n | \n| Professional liability risks<\/td>\n | \n 1,585<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n1,553\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n1,486\n<\/p>\n<\/td>\n<\/tr>\n | \n| Right-of-use operating lease obligations<\/td>\n | \n 1,767<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n1,730\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n1,673\n<\/p>\n<\/td>\n<\/tr>\n | \n| Income taxes and other liabilities<\/td>\n | \n 2,088<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n2,032\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n1,940\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | \u00a0<\/td>\n<\/tr>\n | \n| Stockholders’ equity:<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Stockholders’ (deficit) equity attributable to HCA Healthcare, Inc.<\/td>\n | \n (593)<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n247\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n572\n<\/p>\n<\/td>\n<\/tr>\n | \n| Noncontrolling interests<\/td>\n | \n 2,383<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n2,235\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n2,320\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n\n 1,790<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n2,482\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n2,892\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n\n $48,164<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$47,277\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$47,490\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\nHCA Healthcare, Inc.<\/b><\/td>\n<\/tr>\n\nCondensed Consolidated Statements of Cash Flows<\/b><\/td>\n<\/tr>\n\nFor the Six Months Ended June 30, 2021 and 2020<\/b><\/td>\n<\/tr>\n\n(Dollars in millions)<\/b><\/td>\n<\/tr>\n\n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n | \n | \n\n 2021<\/b><\/p>\n<\/td>\n | | \n\n \n2020\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Cash flows from operating activities:<\/td>\n | | \n | \n | \n | <\/tr>\n \n| Net income<\/td>\n | | \n\n $3,244<\/b><\/p>\n<\/td>\n | | \n\n \n$1,914\n<\/p>\n<\/td>\n<\/tr>\n | \n| Adjustments to reconcile net income to net cash provided by operating activities:<\/td>\n | | \n | \n | \n | <\/tr>\n \n| Increase (decrease) in cash from operating assets and liabilities:<\/td>\n | | \n | \n | \n | <\/tr>\n \n| Accounts receivable<\/td>\n | | \n\n (567)<\/b><\/p>\n<\/td>\n | | \n\n \n1,215\n<\/p>\n<\/td>\n<\/tr>\n | \n| Inventories and other assets<\/td>\n | | \n\n (213)<\/b><\/p>\n<\/td>\n | | \n\n \n(57)\n<\/p>\n<\/td>\n<\/tr>\n | \n| Accounts payable and accrued expenses<\/td>\n | | \n\n 49<\/b><\/p>\n<\/td>\n | | \n\n \n(336)\n<\/p>\n<\/td>\n<\/tr>\n | \n| Contract liabilities – deferred revenues<\/td>\n | | \n\n –<\/b><\/p>\n<\/td>\n | | \n\n \n4,999\n<\/p>\n<\/td>\n<\/tr>\n | \n| Depreciation and amortization<\/td>\n | | \n\n 1,409<\/b><\/p>\n<\/td>\n | | \n\n \n1,365\n<\/p>\n<\/td>\n<\/tr>\n | \n| Income taxes<\/td>\n | | \n\n 2<\/b><\/p>\n<\/td>\n | | \n\n \n472\n<\/p>\n<\/td>\n<\/tr>\n | \n| Losses (gains) on sales of facilities<\/td>\n | | \n\n (10)<\/b><\/p>\n<\/td>\n | | \n\n \n20\n<\/p>\n<\/td>\n<\/tr>\n | \n| Losses on retirement of debt<\/td>\n | | \n\n 12<\/b><\/p>\n<\/td>\n | | \n\n \n295\n<\/p>\n<\/td>\n<\/tr>\n | \n| Amortization of debt issuance costs and discounts<\/td>\n | | \n\n 14<\/b><\/p>\n<\/td>\n | | \n\n \n14\n<\/p>\n<\/td>\n<\/tr>\n | \n| Share-based compensation<\/td>\n | | \n\n 226<\/b><\/p>\n<\/td>\n | | \n\n \n148\n<\/p>\n<\/td>\n<\/tr>\n | \n| Other<\/td>\n | | \n\n 73<\/b><\/p>\n<\/td>\n | | \n\n \n49\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Net cash provided by operating activities<\/td>\n | | \n\n 4,239<\/b><\/p>\n<\/td>\n | | \n\n \n10,098\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Cash flows from investing activities:<\/td>\n | | \n | \n | \n | <\/tr>\n \n| Purchase of property and equipment<\/td>\n | | \n\n (1,496)<\/b><\/p>\n<\/td>\n | | \n\n \n(1,598)\n<\/p>\n<\/td>\n<\/tr>\n | \n| Acquisition of hospitals and health care entities<\/td>\n | | \n\n (98)<\/b><\/p>\n<\/td>\n | | \n\n \n(346)\n<\/p>\n<\/td>\n<\/tr>\n | \n| Sales of hospitals and health care entities<\/td>\n | | \n\n 30<\/b><\/p>\n<\/td>\n | | \n\n \n39\n<\/p>\n<\/td>\n<\/tr>\n | \n| Change in investments<\/td>\n | | \n\n (12)<\/b><\/p>\n<\/td>\n | | \n\n \n(11)\n<\/p>\n<\/td>\n<\/tr>\n | \n| Other<\/td>\n | | \n\n 7<\/b><\/p>\n<\/td>\n | | \n\n \n(37)\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Net cash used in investing activities<\/td>\n | | \n\n (1,569)<\/b><\/p>\n<\/td>\n | | \n\n \n(1,953)\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Cash flows from financing activities:<\/td>\n | | \n | \n | \n | <\/tr>\n \n| Issuances of long-term debt<\/td>\n | | \n\n 4,337<\/b><\/p>\n<\/td>\n | | \n\n \n2,700\n<\/p>\n<\/td>\n<\/tr>\n | \n| Net change in revolving credit facilities<\/td>\n | | \n\n 800<\/b><\/p>\n<\/td>\n | | \n\n \n(2,480)\n<\/p>\n<\/td>\n<\/tr>\n | \n| Repayment of long-term debt<\/td>\n | | \n\n (3,731)<\/b><\/p>\n<\/td>\n | | \n\n \n(3,364)\n<\/p>\n<\/td>\n<\/tr>\n | \n| Distributions to noncontrolling interests<\/td>\n | | \n\n (357)<\/b><\/p>\n<\/td>\n | | \n\n \n(199)\n<\/p>\n<\/td>\n<\/tr>\n | \n| Payment of debt issuance costs<\/td>\n | | \n\n (32)<\/b><\/p>\n<\/td>\n | | \n\n \n(35)\n<\/p>\n<\/td>\n<\/tr>\n | \n| Payment of dividends<\/td>\n | | \n\n (325)<\/b><\/p>\n<\/td>\n | | \n\n \n(153)\n<\/p>\n<\/td>\n<\/tr>\n | \n| Repurchase of common stock<\/td>\n | | \n\n (3,814)<\/b><\/p>\n<\/td>\n | | \n\n \n(441)\n<\/p>\n<\/td>\n<\/tr>\n | \n| Other<\/td>\n | | \n\n (224)<\/b><\/p>\n<\/td>\n | | \n\n \n(144)\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Net cash used in financing activities<\/td>\n | | \n\n (3,346)<\/b><\/p>\n<\/td>\n | | \n\n \n(4,116)\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Effect of exchange rate changes on cash and cash equivalents<\/td>\n | | \n\n 3<\/b><\/p>\n<\/td>\n | | \n\n \n(12)\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Change in cash and cash equivalents<\/td>\n | | \n\n (673)<\/b><\/p>\n<\/td>\n | | \n\n \n4,017\n<\/p>\n<\/td>\n<\/tr>\n | \n| Cash and cash equivalents at beginning of period<\/td>\n | | \n\n 1,793<\/b><\/p>\n<\/td>\n | | \n\n \n621\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Cash and cash equivalents at end of period<\/td>\n | | \n\n $1,120<\/b><\/p>\n<\/td>\n | | \n\n \n$4,638\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n | \n | \n | \n | \n\u00a0<\/td>\n<\/tr>\n | \n| Interest payments<\/td>\n | | \n\n $755<\/b><\/p>\n<\/td>\n | | \n\n \n$854\n<\/p>\n<\/td>\n<\/tr>\n | \n| Income tax payments (refunds), net<\/td>\n | | \n\n $844<\/b><\/p>\n<\/td>\n | | \n\n \n$(16)\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n \n\nHCA Healthcare, Inc.<\/b><\/td>\n<\/tr>\n\nOperating Statistics<\/b><\/td>\n<\/tr>\n\n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | For the Six Months<\/b><\/td>\n<\/tr>\n\n | \nSecond Quarter<\/b><\/td>\n | \u00a0<\/td>\n | Ended June 30,<\/b><\/td>\n<\/tr>\n\n | \n\n 2021<\/span><\/b><\/p>\n<\/td>\n | \n \n\u00a0\n<\/p>\n<\/td>\n | \n 2020<\/span><\/b><\/p>\n<\/td>\n | \n \n\u00a0\n<\/p>\n<\/td>\n | \n 2021<\/span><\/b><\/p>\n<\/td>\n | \n \n\u00a0\n<\/p>\n<\/td>\n | \n 2020<\/span><\/b><\/p>\n<\/td>\n<\/tr>\n\n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Operations:<\/b><\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Number of Hospitals<\/td>\n | \n 187<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n186\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 187<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n186\n<\/p>\n<\/td>\n<\/tr>\n | \n| Number of Freestanding Outpatient Surgery Centers*<\/td>\n | \n 122<\/b><\/p>\n<\/td>\n | | \n\n \n122\n<\/p>\n<\/td>\n | | \n\n 122<\/b><\/p>\n<\/td>\n | | \n\n \n122\n<\/p>\n<\/td>\n<\/tr>\n | \n| Licensed Beds at End of Period<\/td>\n | \n 49,693<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n49,403\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 49,693<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n49,403\n<\/p>\n<\/td>\n<\/tr>\n | \n| Weighted Average Beds in Service<\/td>\n | \n 42,464<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n42,309\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 42,413<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n42,243\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Reported:<\/b><\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Admissions<\/td>\n | \n 532,041<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n452,992\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 1,038,421<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n981,236\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 17.5%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 5.8%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n| Equivalent Admissions<\/td>\n | \n 916,212<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n723,136\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 1,748,701<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n1,612,171\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 26.7%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 8.5%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n| Revenue per Equivalent Admission<\/td>\n | \n $ 15,756<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$ 15,305\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n $ 16,248<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$ 14,843\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 2.9%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 9.5%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n| Inpatient Revenue per Admission<\/td>\n | \n $ 16,144<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$ 15,757\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n $ 16,606<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$ 15,152\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 2.5%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 9.6%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Patient Days<\/td>\n | \n 2,629,950<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n2,260,816\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 5,300,991<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n4,883,655\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change .<\/td>\n | \n 16.3%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 8.5%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n| Equivalent Patient Days<\/td>\n | \n 4,535,678<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n3,609,607\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 8,926,869<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n8,023,845\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 25.7%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 11.3%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Inpatient Surgery Cases<\/td>\n | \n 136,460<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n118,591\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 264,050<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n253,736\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 15.1%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 4.1%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n| Outpatient Surgery Cases<\/td>\n | \n 262,107<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n170,911\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 493,335<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n397,230\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 53.4%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 24.2%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Emergency Room Visits<\/td>\n | \n 2,128,428<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n1,516,116\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 3,970,206<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n3,780,823\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 40.4%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 5.0%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Outpatient Revenues as a<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Percentage of Patient Revenues<\/td>\n | \n 38.2%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n31.8%\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 37.0%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n34.8%\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Average Length of Stay (days)<\/td>\n | \n 4.943<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n4.991\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 5.105<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n4.977\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Occupancy (weighted average beds in service)<\/td>\n | \n 68.1%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n58.7%\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 69.1%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n63.5%\n<\/p>\n<\/td>\n<\/tr>\n | \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Same Facility:<\/b><\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Admissions<\/td>\n | \n 530,067<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n450,964\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 1,035,404<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n978,388\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 17.5%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 5.8%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n| Equivalent Admissions<\/td>\n | \n 911,715<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n718,837\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 1,741,550<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n1,605,535\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 26.8%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 8.5%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n| Revenue per Equivalent Admission<\/td>\n | \n $ 15,683<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$ 15,290\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n $ 16,193<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$ 14,786\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 2.6%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 9.5%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n| Inpatient Revenue per Admission<\/td>\n | \n $ 16,168<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$ 15,786\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n $ 16,626<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n$ 15,172\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 2.4%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 9.6%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Inpatient Surgery Cases<\/td>\n | \n 136,027<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n118,293\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 263,608<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n253,011\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 15.0%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 4.2%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n| Outpatient Surgery Cases<\/td>\n | \n 259,263<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n170,025\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 489,233<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n394,747\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 52.5%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 23.9%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| Emergency Room Visits<\/td>\n | \n 2,115,901<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n1,506,441\n<\/p>\n<\/td>\n | \u00a0<\/td>\n | \n 3,952,401<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | \n \n3,758,123\n<\/p>\n<\/td>\n<\/tr>\n | \n| % Change<\/td>\n | \n 40.5%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | \n\u00a0<\/td>\n | \n 5.2%<\/b><\/p>\n<\/td>\n | \u00a0<\/td>\n | | <\/tr>\n \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n | \n | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | \n\u00a0<\/td>\n | | <\/tr>\n \n| * Excludes freestanding endoscopy centers (21 centers at both June 30, 2021 and June 30, 2020).<\/td>\n<\/tr>\n<\/table>\n | | | | | | | | | | | | | | | | | | | | | | | |
![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20210720005191\/en\/707647\/3\/2019_Logo.jpg\"){kind=logo}
<\/td>\n<\/tr>\n